Rossari Biotech Stock

Rossari Biotech Debt

The Debt of Rossari Biotech (ROSSARI.NS) as of Aug 22, 2026 is 2.18 B INR. In the previous year, Debt was 1.19 B INR — a change of 83.51% (higher).

Debt

2.18 BINR

YoY

83.51%

Last updated:

In 2026, Rossari Biotech's total debt was 2.18 B INR, a 83.51% change from the 1.19 B INR total debt recorded in the previous year.

The Rossari Biotech Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2018
209.50 M INR
Jan 1, 2019
45.30 M INR
Jan 1, 2020
669.30 M INR
Jan 1, 2021
0.00 INR
Jan 1, 2022
934.54 M INR
Jan 1, 2023
739.28 M INR
Jan 1, 2024
1.19 B INR
Jan 1, 2025
2.18 B INR
The Rossari Biotech Debt history
YEARDebtYoY
2.18 BINR+83.51%
1.19 BINR+60.69%
739.28 MINR-20.89%
934.54 MINR—
0.00INR-100.00%
669.30 MINR+1,377.48%
45.30 MINR-78.38%
209.50 MINR-13.43%
242.00 MINR-6.99%
260.20 MINR—
Access this data via the Eulerpool API
Get Free API Key

Rossari Biotech Stock analysis

What does Rossari Biotech do? Rossari Biotech is one of the most popular companies on Eulerpool.

Debt Details

Understanding Rossari Biotech's Debt Structure

Rossari Biotech's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Rossari Biotech's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Rossari Biotech’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Rossari Biotech’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Rossari Biotech stock

Debt of Rossari Biotech is 2.18 B INR in 2026.

Debt of Rossari Biotech changed from 1.19 B INR to 2.18 B INR, representing a 83.51% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt Rossari Biotech since 2006 – with annual values, charts, and detailed analysis.

Debt's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Rossari Biotech historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Rossari Biotech

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Rossari Biotech